Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Reward | 18 | 2022 | 940 | 3.330 |
Why?
|
Gambling | 7 | 2017 | 250 | 2.190 |
Why?
|
Behavior, Addictive | 13 | 2022 | 462 | 2.100 |
Why?
|
Cocaine-Related Disorders | 12 | 2008 | 460 | 2.050 |
Why?
|
Naltrexone | 8 | 2020 | 307 | 1.610 |
Why?
|
Benzodiazepines | 5 | 2017 | 1101 | 1.380 |
Why?
|
Stress Disorders, Post-Traumatic | 8 | 2022 | 4266 | 1.060 |
Why?
|
Pituitary-Adrenal System | 5 | 2024 | 553 | 1.040 |
Why?
|
Opioid-Related Disorders | 8 | 2022 | 2064 | 0.970 |
Why?
|
Cocaine | 6 | 2008 | 1007 | 0.940 |
Why?
|
Schizophrenia | 17 | 2017 | 6865 | 0.900 |
Why?
|
Hypothalamo-Hypophyseal System | 5 | 2024 | 703 | 0.880 |
Why?
|
Narcotic Antagonists | 7 | 2020 | 562 | 0.850 |
Why?
|
Pain | 8 | 2018 | 4987 | 0.850 |
Why?
|
Motivation | 7 | 2017 | 1971 | 0.810 |
Why?
|
Hydrocortisone | 10 | 2005 | 1826 | 0.780 |
Why?
|
Antipsychotic Agents | 11 | 2017 | 3057 | 0.740 |
Why?
|
Deoxyglucose | 7 | 2004 | 337 | 0.690 |
Why?
|
Hallucinogens | 1 | 2021 | 177 | 0.650 |
Why?
|
Brain | 25 | 2021 | 26345 | 0.640 |
Why?
|
Stress, Physiological | 4 | 2024 | 1403 | 0.620 |
Why?
|
Beauty | 2 | 2009 | 42 | 0.610 |
Why?
|
Cerebrum | 1 | 2018 | 137 | 0.590 |
Why?
|
Avoidance Learning | 1 | 2018 | 233 | 0.590 |
Why?
|
Glucose Tolerance Test | 2 | 2017 | 1151 | 0.580 |
Why?
|
Substance-Related Disorders | 7 | 2022 | 4254 | 0.570 |
Why?
|
Stress, Psychological | 6 | 2024 | 4245 | 0.540 |
Why?
|
Unconsciousness | 1 | 2018 | 263 | 0.540 |
Why?
|
Adrenocorticotropic Hormone | 5 | 2003 | 648 | 0.530 |
Why?
|
Psychotic Disorders | 5 | 2017 | 3044 | 0.520 |
Why?
|
Clozapine | 7 | 2006 | 498 | 0.470 |
Why?
|
Awareness | 1 | 2018 | 639 | 0.460 |
Why?
|
Nerve Net | 5 | 2013 | 2173 | 0.440 |
Why?
|
Norepinephrine | 5 | 2004 | 909 | 0.430 |
Why?
|
Comorbidity | 4 | 2022 | 10380 | 0.430 |
Why?
|
Consciousness | 1 | 2018 | 571 | 0.420 |
Why?
|
Yohimbine | 1 | 2012 | 61 | 0.420 |
Why?
|
Appetite Depressants | 1 | 2012 | 110 | 0.410 |
Why?
|
Face | 2 | 2009 | 993 | 0.390 |
Why?
|
Sucrose | 1 | 2011 | 164 | 0.380 |
Why?
|
Brain Mapping | 4 | 2018 | 6622 | 0.380 |
Why?
|
Amygdala | 4 | 2016 | 1313 | 0.370 |
Why?
|
Dopamine | 10 | 2022 | 1592 | 0.360 |
Why?
|
Dopamine Agonists | 2 | 2018 | 355 | 0.340 |
Why?
|
Emotions | 4 | 2021 | 2656 | 0.330 |
Why?
|
Blood Glucose | 3 | 2017 | 6259 | 0.330 |
Why?
|
Suicide | 2 | 2021 | 1476 | 0.310 |
Why?
|
Analgesics, Opioid | 8 | 2022 | 3677 | 0.310 |
Why?
|
Delayed-Action Preparations | 5 | 2020 | 967 | 0.300 |
Why?
|
Antimetabolites | 2 | 2004 | 125 | 0.290 |
Why?
|
Heroin Dependence | 3 | 2015 | 175 | 0.290 |
Why?
|
Psychiatric Status Rating Scales | 10 | 2017 | 6030 | 0.280 |
Why?
|
Adult | 55 | 2021 | 213889 | 0.280 |
Why?
|
Combat Disorders | 1 | 2008 | 302 | 0.270 |
Why?
|
Prolactin | 2 | 2005 | 668 | 0.260 |
Why?
|
Humans | 91 | 2024 | 743811 | 0.250 |
Why?
|
Risperidone | 3 | 2002 | 383 | 0.250 |
Why?
|
Cues | 5 | 2015 | 874 | 0.250 |
Why?
|
Analysis of Variance | 8 | 2012 | 6356 | 0.240 |
Why?
|
Energy Intake | 1 | 2012 | 2149 | 0.240 |
Why?
|
Dopamine Uptake Inhibitors | 4 | 2002 | 312 | 0.240 |
Why?
|
Dopamine Antagonists | 5 | 2002 | 296 | 0.240 |
Why?
|
Psychomotor Performance | 2 | 2013 | 1895 | 0.230 |
Why?
|
Culture | 1 | 2008 | 632 | 0.230 |
Why?
|
Male | 62 | 2021 | 349776 | 0.230 |
Why?
|
Personal Satisfaction | 1 | 2008 | 641 | 0.230 |
Why?
|
Catecholamines | 1 | 2004 | 387 | 0.220 |
Why?
|
Pilot Projects | 9 | 2021 | 8316 | 0.220 |
Why?
|
Behavior | 4 | 2019 | 559 | 0.220 |
Why?
|
Sympathetic Fibers, Postganglionic | 1 | 2002 | 13 | 0.220 |
Why?
|
Neurobiology | 2 | 2018 | 121 | 0.220 |
Why?
|
Growth Hormone | 1 | 2005 | 705 | 0.210 |
Why?
|
Female | 56 | 2021 | 380020 | 0.210 |
Why?
|
Sex Characteristics | 2 | 2011 | 2583 | 0.210 |
Why?
|
Solitary Nucleus | 1 | 2022 | 63 | 0.210 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2017 | 10940 | 0.210 |
Why?
|
Methoxyhydroxyphenylglycol | 2 | 2001 | 93 | 0.210 |
Why?
|
Serotonin Antagonists | 1 | 2002 | 144 | 0.210 |
Why?
|
Weight Gain | 1 | 2012 | 2294 | 0.210 |
Why?
|
Vasopressins | 1 | 2003 | 370 | 0.200 |
Why?
|
Double-Blind Method | 11 | 2013 | 12020 | 0.200 |
Why?
|
Patient Acceptance of Health Care | 3 | 2016 | 3020 | 0.200 |
Why?
|
Adipose Tissue | 1 | 2013 | 3280 | 0.200 |
Why?
|
Epinephrine | 2 | 2004 | 792 | 0.200 |
Why?
|
Peripheral Nervous System | 1 | 2002 | 150 | 0.200 |
Why?
|
Analgesics | 2 | 2021 | 1040 | 0.190 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2016 | 1951 | 0.190 |
Why?
|
Depressive Disorder | 3 | 2006 | 3744 | 0.180 |
Why?
|
Visual Perception | 2 | 2008 | 1414 | 0.180 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2002 | 632 | 0.170 |
Why?
|
Testosterone | 2 | 2001 | 2297 | 0.170 |
Why?
|
Triglycerides | 2 | 2017 | 2453 | 0.170 |
Why?
|
Eating | 1 | 2006 | 1536 | 0.170 |
Why?
|
Self Disclosure | 1 | 2000 | 251 | 0.160 |
Why?
|
Inappropriate Prescribing | 1 | 2021 | 202 | 0.160 |
Why?
|
Psychiatry | 1 | 2011 | 1694 | 0.160 |
Why?
|
Mental Recall | 1 | 2004 | 1206 | 0.160 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5752 | 0.160 |
Why?
|
Insulin Resistance | 3 | 2017 | 3863 | 0.160 |
Why?
|
Severity of Illness Index | 8 | 2011 | 15526 | 0.150 |
Why?
|
Middle Aged | 21 | 2021 | 213241 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 14 | 2018 | 35409 | 0.140 |
Why?
|
Autonomic Nervous System | 1 | 2022 | 671 | 0.140 |
Why?
|
Adrenal Cortex | 1 | 1997 | 140 | 0.140 |
Why?
|
Injections, Intramuscular | 2 | 2020 | 553 | 0.140 |
Why?
|
Rare Diseases | 1 | 2021 | 552 | 0.140 |
Why?
|
Affect | 3 | 2011 | 1473 | 0.140 |
Why?
|
Drug-Seeking Behavior | 1 | 2016 | 48 | 0.130 |
Why?
|
Maternal Behavior | 1 | 2017 | 311 | 0.130 |
Why?
|
Homovanillic Acid | 3 | 2004 | 75 | 0.120 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2016 | 369 | 0.120 |
Why?
|
Veterans | 1 | 2008 | 2519 | 0.120 |
Why?
|
Methylphenidate | 3 | 2006 | 473 | 0.120 |
Why?
|
Marijuana Abuse | 2 | 2008 | 403 | 0.120 |
Why?
|
Infusions, Intravenous | 4 | 2005 | 2274 | 0.120 |
Why?
|
Body Mass Index | 3 | 2017 | 12718 | 0.120 |
Why?
|
Attention | 1 | 2004 | 2393 | 0.120 |
Why?
|
Pituitary Gland | 1 | 1997 | 664 | 0.120 |
Why?
|
Statistics as Topic | 2 | 2016 | 2369 | 0.120 |
Why?
|
Neostriatum | 3 | 2000 | 249 | 0.120 |
Why?
|
Interview, Psychological | 1 | 2017 | 812 | 0.110 |
Why?
|
Anesthesia, General | 1 | 2001 | 1171 | 0.110 |
Why?
|
Mental Disorders | 2 | 2011 | 6593 | 0.110 |
Why?
|
Insulin | 1 | 2008 | 6584 | 0.110 |
Why?
|
Community Mental Health Services | 1 | 2016 | 386 | 0.110 |
Why?
|
Product Labeling | 1 | 2013 | 79 | 0.110 |
Why?
|
Cross-Over Studies | 3 | 2011 | 2029 | 0.110 |
Why?
|
Neural Pathways | 4 | 2016 | 2971 | 0.110 |
Why?
|
Social Stigma | 1 | 2019 | 701 | 0.110 |
Why?
|
Event-Related Potentials, P300 | 1 | 2013 | 149 | 0.110 |
Why?
|
Hydroxyindoleacetic Acid | 2 | 2003 | 90 | 0.110 |
Why?
|
Drug Resistance | 1 | 2018 | 1606 | 0.110 |
Why?
|
Cerebrovascular Circulation | 2 | 2002 | 2732 | 0.110 |
Why?
|
Adrenergic alpha-2 Receptor Antagonists | 1 | 2012 | 14 | 0.110 |
Why?
|
Regression Analysis | 3 | 2017 | 6457 | 0.110 |
Why?
|
Progesterone | 1 | 1997 | 773 | 0.100 |
Why?
|
Liver Function Tests | 1 | 2013 | 529 | 0.100 |
Why?
|
Appetite Regulation | 1 | 2012 | 88 | 0.100 |
Why?
|
Cerebellar Diseases | 1 | 2014 | 226 | 0.100 |
Why?
|
Injections, Intraperitoneal | 1 | 2012 | 424 | 0.100 |
Why?
|
Taste Perception | 1 | 2011 | 30 | 0.100 |
Why?
|
Arousal | 1 | 2017 | 1160 | 0.100 |
Why?
|
Amphetamine | 3 | 2002 | 225 | 0.090 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 3 | 2006 | 3655 | 0.090 |
Why?
|
Homeostasis | 2 | 2022 | 3337 | 0.090 |
Why?
|
Metabolic Clearance Rate | 2 | 2002 | 380 | 0.090 |
Why?
|
Dihydroxyphenylalanine | 2 | 2001 | 76 | 0.090 |
Why?
|
Migraine Disorders | 1 | 2021 | 1620 | 0.080 |
Why?
|
Educational Status | 1 | 2017 | 2540 | 0.080 |
Why?
|
Outpatients | 1 | 2016 | 1488 | 0.080 |
Why?
|
Rats, Wistar | 1 | 2012 | 1892 | 0.080 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 4 | 1999 | 896 | 0.080 |
Why?
|
Analgesia | 1 | 2013 | 461 | 0.080 |
Why?
|
Ketamine | 3 | 1999 | 501 | 0.080 |
Why?
|
Affective Symptoms | 1 | 2011 | 405 | 0.080 |
Why?
|
Tomography, Emission-Computed | 6 | 2002 | 1143 | 0.080 |
Why?
|
Random Allocation | 1 | 2012 | 2429 | 0.080 |
Why?
|
Drug Interactions | 1 | 2012 | 1460 | 0.080 |
Why?
|
Time Factors | 6 | 2009 | 40038 | 0.080 |
Why?
|
Heroin | 1 | 2007 | 117 | 0.070 |
Why?
|
Disease Progression | 1 | 2024 | 13273 | 0.070 |
Why?
|
Neuropsychological Tests | 2 | 2013 | 6976 | 0.070 |
Why?
|
Cerebellum | 1 | 2014 | 1487 | 0.070 |
Why?
|
Substance Abuse, Intravenous | 1 | 2011 | 525 | 0.070 |
Why?
|
Anorexia Nervosa | 2 | 1992 | 1286 | 0.070 |
Why?
|
Heart Rate | 3 | 2002 | 4091 | 0.070 |
Why?
|
Injections, Intravenous | 2 | 2011 | 1422 | 0.070 |
Why?
|
Self Report | 1 | 2017 | 3550 | 0.070 |
Why?
|
Oxidative Stress | 1 | 1997 | 3082 | 0.070 |
Why?
|
Methadone | 1 | 2007 | 306 | 0.060 |
Why?
|
Animals | 8 | 2022 | 168660 | 0.060 |
Why?
|
Pain, Intractable | 1 | 2006 | 130 | 0.060 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 1997 | 449 | 0.060 |
Why?
|
Color Perception | 1 | 2006 | 213 | 0.060 |
Why?
|
Education | 1 | 2008 | 543 | 0.060 |
Why?
|
Patient Compliance | 1 | 2015 | 2683 | 0.060 |
Why?
|
Behavior, Animal | 1 | 2012 | 1880 | 0.060 |
Why?
|
Leptin | 1 | 2012 | 1600 | 0.060 |
Why?
|
Syndrome | 2 | 2022 | 3249 | 0.060 |
Why?
|
Central Nervous System Stimulants | 2 | 2006 | 1148 | 0.060 |
Why?
|
Prevalence | 2 | 2016 | 15211 | 0.060 |
Why?
|
Buprenorphine | 1 | 2011 | 640 | 0.060 |
Why?
|
Single-Blind Method | 1 | 2007 | 1586 | 0.060 |
Why?
|
Oxygen | 3 | 2012 | 4189 | 0.060 |
Why?
|
Heterosexuality | 1 | 2005 | 275 | 0.060 |
Why?
|
Depression | 2 | 2021 | 7760 | 0.060 |
Why?
|
Raclopride | 5 | 2002 | 97 | 0.060 |
Why?
|
Public Policy | 1 | 2007 | 572 | 0.060 |
Why?
|
Schizotypal Personality Disorder | 1 | 2004 | 288 | 0.050 |
Why?
|
Schizophrenic Psychology | 3 | 1999 | 1671 | 0.050 |
Why?
|
Streptothricins | 1 | 2022 | 6 | 0.050 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 2002 | 47 | 0.050 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2002 | 64 | 0.050 |
Why?
|
Bipolar Disorder | 2 | 2011 | 5027 | 0.050 |
Why?
|
Lipids | 1 | 2013 | 3307 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17439 | 0.050 |
Why?
|
Young Adult | 5 | 2021 | 56392 | 0.050 |
Why?
|
Photic Stimulation | 3 | 2013 | 2019 | 0.050 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 2001 | 64 | 0.050 |
Why?
|
Blood Pressure | 3 | 2002 | 8551 | 0.050 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2002 | 166 | 0.050 |
Why?
|
Sympathetic Nervous System | 1 | 2004 | 513 | 0.050 |
Why?
|
Health Policy | 1 | 2013 | 2662 | 0.050 |
Why?
|
Thirst | 1 | 2001 | 38 | 0.050 |
Why?
|
Medulla Oblongata | 1 | 2022 | 243 | 0.050 |
Why?
|
Radioimmunoassay | 1 | 2001 | 916 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2011 | 8939 | 0.050 |
Why?
|
Task Performance and Analysis | 1 | 2004 | 779 | 0.050 |
Why?
|
N-Methylaspartate | 2 | 1998 | 231 | 0.050 |
Why?
|
Receptors, Dopamine D2 | 2 | 2002 | 475 | 0.040 |
Why?
|
Feeding Behavior | 1 | 2012 | 3187 | 0.040 |
Why?
|
Memory | 1 | 2009 | 2173 | 0.040 |
Why?
|
Hunger | 1 | 2001 | 198 | 0.040 |
Why?
|
Receptors, Dopamine | 1 | 2000 | 295 | 0.040 |
Why?
|
Time | 1 | 2001 | 542 | 0.040 |
Why?
|
Illness Behavior | 1 | 2018 | 22 | 0.040 |
Why?
|
Catechols | 1 | 1999 | 61 | 0.040 |
Why?
|
Serotonin | 1 | 2003 | 1017 | 0.040 |
Why?
|
Cognition Disorders | 2 | 2006 | 4041 | 0.040 |
Why?
|
Neurotransmitter Agents | 1 | 2022 | 646 | 0.040 |
Why?
|
Parkinson Disease, Secondary | 1 | 1999 | 126 | 0.040 |
Why?
|
Monoamine Oxidase | 1 | 1999 | 178 | 0.040 |
Why?
|
Tritium | 1 | 1999 | 745 | 0.040 |
Why?
|
Fluphenazine | 1 | 1998 | 36 | 0.040 |
Why?
|
Neural Inhibition | 1 | 2002 | 598 | 0.040 |
Why?
|
Vasodilation | 1 | 2002 | 944 | 0.040 |
Why?
|
Fentanyl | 1 | 2001 | 409 | 0.040 |
Why?
|
Placebos | 1 | 2002 | 1674 | 0.040 |
Why?
|
Body Temperature | 1 | 2001 | 774 | 0.040 |
Why?
|
Hair | 1 | 2001 | 480 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2002 | 1108 | 0.040 |
Why?
|
Chronic Disease | 2 | 2011 | 9139 | 0.040 |
Why?
|
Brain Stem | 1 | 2022 | 844 | 0.040 |
Why?
|
Smoking | 1 | 2013 | 8984 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2005 | 39001 | 0.040 |
Why?
|
Synaptic Transmission | 1 | 2002 | 1176 | 0.030 |
Why?
|
Rats | 1 | 2012 | 24250 | 0.030 |
Why?
|
Truth Disclosure | 1 | 2000 | 436 | 0.030 |
Why?
|
Adolescent | 8 | 2022 | 85729 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 1999 | 1525 | 0.030 |
Why?
|
Salicylamides | 3 | 1999 | 33 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2001 | 2883 | 0.030 |
Why?
|
Personality | 1 | 1998 | 552 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2006 | 2899 | 0.030 |
Why?
|
Phencyclidine | 1 | 1994 | 61 | 0.030 |
Why?
|
Respiration | 1 | 2001 | 1653 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2012 | 21733 | 0.030 |
Why?
|
Estrogens | 1 | 2001 | 1563 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2014 | 6237 | 0.030 |
Why?
|
Sex Factors | 2 | 2013 | 10394 | 0.030 |
Why?
|
Hypoglycemia | 1 | 2001 | 861 | 0.030 |
Why?
|
Secondary Prevention | 2 | 2012 | 1529 | 0.030 |
Why?
|
Depressive Disorder, Major | 1 | 2011 | 4635 | 0.030 |
Why?
|
Synapses | 1 | 2002 | 1728 | 0.030 |
Why?
|
Cognition | 2 | 2022 | 6759 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2008 | 5692 | 0.030 |
Why?
|
Administration, Sublingual | 1 | 2011 | 56 | 0.030 |
Why?
|
Aged | 3 | 2021 | 163178 | 0.030 |
Why?
|
Massachusetts | 1 | 2003 | 8660 | 0.020 |
Why?
|
Risk Factors | 2 | 2016 | 72252 | 0.020 |
Why?
|
Aging | 1 | 2008 | 8655 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8337 | 0.020 |
Why?
|
Carbon Radioisotopes | 2 | 2000 | 577 | 0.020 |
Why?
|
Infant | 1 | 2009 | 35122 | 0.020 |
Why?
|
Military Personnel | 1 | 2016 | 1133 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4288 | 0.020 |
Why?
|
Acute Disease | 2 | 2007 | 7150 | 0.020 |
Why?
|
Hot Temperature | 1 | 2011 | 1351 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7784 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2000 | 14714 | 0.020 |
Why?
|
Length of Stay | 1 | 1998 | 6311 | 0.020 |
Why?
|
Corpus Striatum | 2 | 2002 | 1219 | 0.010 |
Why?
|
Drug Administration Schedule | 2 | 2004 | 4931 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16361 | 0.010 |
Why?
|
Pyruvic Acid | 1 | 2004 | 200 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2401 | 0.010 |
Why?
|
Pain Measurement | 1 | 2013 | 3420 | 0.010 |
Why?
|
Incidence | 1 | 2001 | 20948 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5952 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15518 | 0.010 |
Why?
|
Family | 1 | 1992 | 3144 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2007 | 1395 | 0.010 |
Why?
|
Functional Laterality | 1 | 2007 | 2280 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 77410 | 0.010 |
Why?
|
Glucose | 2 | 2004 | 4398 | 0.010 |
Why?
|
Radioligand Assay | 1 | 2000 | 374 | 0.010 |
Why?
|
Reaction Time | 1 | 2006 | 2091 | 0.010 |
Why?
|
Hippocampus | 2 | 2004 | 3672 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2006 | 1311 | 0.010 |
Why?
|
Neurons | 1 | 1998 | 9336 | 0.010 |
Why?
|
Basal Ganglia Diseases | 1 | 1999 | 148 | 0.010 |
Why?
|
Hospitalization | 1 | 1998 | 10259 | 0.010 |
Why?
|
Psychoses, Substance-Induced | 1 | 1998 | 96 | 0.010 |
Why?
|
Models, Biological | 1 | 2014 | 9582 | 0.010 |
Why?
|
Fear | 1 | 2006 | 1438 | 0.010 |
Why?
|
Prognosis | 1 | 1998 | 29052 | 0.010 |
Why?
|
Choline | 1 | 1998 | 492 | 0.010 |
Why?
|
Personality Assessment | 1 | 1998 | 647 | 0.010 |
Why?
|
Prospective Studies | 1 | 2001 | 53250 | 0.010 |
Why?
|
Creatine | 1 | 1998 | 421 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 57744 | 0.010 |
Why?
|
Aspartic Acid | 1 | 1998 | 576 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 2006 | 2684 | 0.010 |
Why?
|
Patient Care Team | 1 | 2006 | 2528 | 0.010 |
Why?
|
Brain Chemistry | 1 | 1998 | 982 | 0.010 |
Why?
|
Human Growth Hormone | 1 | 1999 | 684 | 0.010 |
Why?
|
Radiography | 1 | 2004 | 7010 | 0.010 |
Why?
|
Binding Sites | 1 | 2002 | 6111 | 0.010 |
Why?
|
Reference Values | 1 | 2000 | 4974 | 0.010 |
Why?
|
Family Therapy | 1 | 1992 | 207 | 0.010 |
Why?
|
Prefrontal Cortex | 1 | 1998 | 2147 | 0.000 |
Why?
|
Child | 2 | 2006 | 77637 | 0.000 |
Why?
|
Health Status | 1 | 1998 | 4031 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1999 | 12954 | 0.000 |
Why?
|
Treatment Outcome | 2 | 1999 | 63042 | 0.000 |
Why?
|